Viofar
Viofar is a privately-held Greek pharmaceutical and cosmetical laboratory founded in 1993, headquartered in Acharnes near Athens, producing and distributing health products with a workforce of 11–50 employees.
- Company typePrivate
- Founded1993
- HeadquartersAkharnaí, Greece
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Viofar does
Viofar Ltd Pharmaceutical & Cosmetical Laboratories is a privately-held Greek pharmaceutical and cosmetical laboratory founded in 1993 and headquartered in Acharnes (a suburb of Athens), Greece. According to available firmographic data, the company specializes in the production and distribution of health products, operating within the pharmaceutical and cosmetics sectors. The company's legal entity is registered as a private limited company in Greece, with a workforce of 11–50 employees, indicating a small-to-mid-sized specialty manufacturer rather than a mass-market producer.
No detailed product catalog, specific therapeutic or cosmetic product lines, active pharmaceutical ingredients, formulation capabilities, or manufacturing capacity figures are disclosed in the available data. The company website (viofar.gr) is currently under construction, displaying only a placeholder page with company name, address, and a contact form, providing no further visibility into the underlying products, technology stack, or distribution mechanics. There is no disclosed pricing model, revenue model, go-to-market motion, or customer segmentation in the source material.
The company's business model cannot be precisely characterized from available evidence. It serves the Greek market within Southeast Europe based on geographic inference from its registered address, but no distribution channels, named customers, partnerships, certifications, regulatory licenses, or ownership structure are publicly disclosed. The lack of disclosed financials, funding history, management team, or third-party validation means that operational scale, revenue base, and strategic direction remain unverified from primary sources.
Viofar firmographics
Firmographics- Name
- Viofar
- Legal name
- Viofar Ltd Pharmaceutical & Cosmetical Laboratories
- Website
- https://viofar.gr
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Viofar is a privately-held Greek pharmaceutical and cosmetical laboratory founded in 1993, headquartered in Acharnes near Athens, producing and distributing health products with a workforce of 11–50 employees.
- Ownership category
- akta.pro rank
Where Viofar is headquartered
LocationHeadquarters
- HQ city
- Akharnaí
- HQ country
- Greece
- HQ region
- Europe
Offices1 record
Markets served
Viofar business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales
Viofar product offering
Product offeringCore offering
Viofar is a Greek pharmaceutical and cosmetical laboratory that specializes in the production and distribution of health products. Operating since 1993, the company manufactures pharmaceutical and cosmetic offerings from its headquarters in Acharnes, Greece. The company website is currently under construction, so detailed product catalog information is not publicly available.
Product overview
Viofar Ltd is a pharmaceutical and cosmetical laboratory company. The company website is currently under construction, with no product catalog, service offerings, or detailed product information available at this time.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Products
- Cosmetical Products
Companies that use Viofar
Customer profileIdeal customer profiles1 record
Viofar technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Viofar partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Viofar competitors and assessment
Company assessmentDirect peers
- Lavipharm SA: Lavipharm is a Greek pharmaceutical and personal-care company operating in both medicines and cosmetics/dermo-cosmetics. It is directly comparable to Viofar's pharma-plus-cosmetics platform and similar Greek mid-market scale.
- Vianex SA: Vianex is a long-established Greek pharmaceutical manufacturer offering a wide portfolio of human medicines, cosmetics, and consumer health products. It is highly comparable given Viofar's combined pharma-and-cosmetics manufacturing focus and similar Greek private-company profile.
- Demo SA Pharmaceutical Industry: Demo is a major Greek pharmaceutical manufacturer specializing in sterile injectables, generics, and contract manufacturing. It directly competes with Viofar in Greek pharmaceutical production and shares the same private, manufacturing-focused profile.
- ELPEN Pharmaceutical Co. Inc. ELPEN is one of the largest Greek pharmaceutical manufacturers, producing generic and branded medicines as well as some consumer health products. It is directly comparable as a Greek-based pharma manufacturer operating in the same domestic regulatory environment and serving overlapping channels.
- Uni-Pharma SA: Uni-Pharma is a Greek pharmaceutical manufacturer with a broad generics and specialty portfolio and exports across Europe. Comparable to Viofar as another privately held Greek pharma manufacturer targeting similar therapeutic and consumer health categories.
- Help Pharmaceuticals: Help Pharmaceuticals is a Greek manufacturer of generic and specialty pharmaceutical products. Comparable to Viofar as a privately held Greek pharma manufacturer serving the domestic and adjacent Southeast European markets.
- Galenica SA: Galenica is a Greek pharmaceutical company with manufacturing, marketing, and export operations across multiple therapeutic areas. It is a close peer given the overlap in Greek-manufactured pharmaceutical offerings and similar mid-sized private profile.
Broad incumbents
- STADA Arzneimittel AG: STADA is a large European generics and consumer healthcare company with manufacturing and marketing across multiple EU markets. Comparable as a broad incumbent in the same generic-pharma and consumer-health categories where Viofar operates, though at a far larger scale.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks1 record
Customer concentration
Viofar social profiles
Digital presenceViofar financial estimates
Financial estimateRevenue estimate
Valuation estimate
Viofar leadership team
Management profileNumber of profiles
Viofar funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Viofar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Viofar
What does Viofar do?
Viofar is a Greek pharmaceutical and cosmetical laboratory that specializes in the production and distribution of health products. Operating since 1993, the company manufactures pharmaceutical and cosmetic offerings from its headquarters in Acharnes, Greece. The company website is currently under construction, so detailed product catalog information is not publicly available.
Is Viofar a public or private company?
Viofar is a private company. It is classified as unknown and is currently operating.
When was Viofar founded?
Viofar was founded in 1993. It employs 11 to 50 people.
Where is Viofar based?
Viofar is headquartered in Akharnaí, Greece, in the Europe region.
Who are Viofar's main competitors?
Direct peers on record are Lavipharm SA, Vianex SA, Demo SA Pharmaceutical Industry, ELPEN Pharmaceutical Co. Inc., Uni-Pharma SA, Help Pharmaceuticals and Galenica SA. STADA Arzneimittel AG is listed as a broad incumbent.
Does Viofar have an API?
No public API is recorded for Viofar.